Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CEBPD |
| Upstream (Parents) |
|---|
| (<<) HLF → CEBPD |
| (<<) SALL1 → CEBPD |
| (<<) NR1H4 → CEBPD |
| (<<) ESR1 → CEBPD |
| (<<) ATF5 → CEBPD |
| (<<) HHEX → CEBPD |
| (<<) SOX9 → CEBPD |
| (<<) NR3C1 → CEBPD |
| Downstream (Children) |
|---|
| CEBPD → SLC26A3 (>>) |
| CEBPD → ZIC1 (>>) |
| CEBPD → ETV4 (>>) |
| CEBPD → HOXB9 (>>) |
| CEBPD → KLF15 (>>) |
| CEBPD → GRHL2 (>>) |
| CEBPD → MAF (>>) |
| CEBPD → TLX1 (>>) |
| CEBPD → MZF1 (>>) |
| CEBPD → NR4A1 (>>) |
| CEBPD → EVX1 (>>) |
| CEBPD → MEIS2 (>>) |
| CEBPD → AFF1 (>>) |
| CEBPD → ELF3 (>>) |
| CEBPD → PLAGL2 (>>) |
| CEBPD → HSF4 (>>) |
| CEBPD → GTF2IRD1 (>>) |
